141 related articles for article (PubMed ID: 20166965)
1. Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research.
Dietz GP
Curr Pharm Biotechnol; 2010 Feb; 11(2):167-74. PubMed ID: 20166965
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of cell-penetrating peptides and their application in neurobiology.
Dietz GP; Bähr M
Methods Mol Biol; 2007; 399():181-98. PubMed ID: 18309933
[TBL] [Abstract][Full Text] [Related]
3. Effects of protein transduction domain (PTD) selection and position for improved intracellular delivery of PTD-Hsp27 fusion protein formulations.
Ul Ain Q; Lee JH; Woo YS; Kim YH
Arch Pharm Res; 2016 Sep; 39(9):1266-74. PubMed ID: 27381220
[TBL] [Abstract][Full Text] [Related]
4. Peptide-enhanced cellular internalization of proteins in neuroscience.
Dietz GP; Bähr M
Brain Res Bull; 2005 Dec; 68(1-2):103-14. PubMed ID: 16325010
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides.
Bolhassani A; Jafarzade BS; Mardani G
Peptides; 2017 Jan; 87():50-63. PubMed ID: 27887988
[TBL] [Abstract][Full Text] [Related]
6. Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation.
Kadonosono T; Yamano A; Goto T; Tsubaki T; Niibori M; Kuchimaru T; Kizaka-Kondoh S
J Control Release; 2015 Mar; 201():14-21. PubMed ID: 25592386
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo.
Kim D; Jeon C; Kim JH; Kim MS; Yoon CH; Choi IS; Kim SH; Bae YS
Exp Cell Res; 2006 May; 312(8):1277-88. PubMed ID: 16466653
[TBL] [Abstract][Full Text] [Related]
8. Protein cargo delivery properties of cell-penetrating peptides. A comparative study.
Säälik P; Elmquist A; Hansen M; Padari K; Saar K; Viht K; Langel U; Pooga M
Bioconjug Chem; 2004; 15(6):1246-53. PubMed ID: 15546190
[TBL] [Abstract][Full Text] [Related]
9. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
10. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
11. Taming the Wildness of "Trojan-Horse" Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents.
Shi NQ; Qi XR
ACS Appl Mater Interfaces; 2017 Mar; 9(12):10519-10529. PubMed ID: 28290666
[TBL] [Abstract][Full Text] [Related]
12. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
[TBL] [Abstract][Full Text] [Related]
13. Fusion polypeptides that inhibit exocytosis: fusing aptamer and cell-penetrating peptide technologies and pharmacologies.
Eiden LE
Mol Pharmacol; 2005 Apr; 67(4):980-2. PubMed ID: 15673600
[TBL] [Abstract][Full Text] [Related]
14. The taming of the cell penetrating domain of the HIV Tat: myths and realities.
Chauhan A; Tikoo A; Kapur AK; Singh M
J Control Release; 2007 Feb; 117(2):148-62. PubMed ID: 17196289
[TBL] [Abstract][Full Text] [Related]
15. Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.
Pardridge WM
BioDrugs; 2017 Dec; 31(6):503-519. PubMed ID: 29067674
[TBL] [Abstract][Full Text] [Related]
16. Intracellular transduction using cell-penetrating peptides.
Sawant R; Torchilin V
Mol Biosyst; 2010 Apr; 6(4):628-40. PubMed ID: 20237640
[TBL] [Abstract][Full Text] [Related]
17. Cell penetrating peptides for in vivo molecular imaging applications.
Kersemans V; Kersemans K; Cornelissen B
Curr Pharm Des; 2008; 14(24):2415-47. PubMed ID: 18781991
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
19. Protein engineering and design for drug delivery.
Murphy JR
Curr Opin Struct Biol; 1996 Aug; 6(4):541-5. PubMed ID: 8794167
[TBL] [Abstract][Full Text] [Related]
20. Predicting cell-penetrating peptides.
Hansen M; Kilk K; Langel U
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
